ProMIS Neurosciences Files Q1 2025 10-Q
Ticker: PMN · Form: 10-Q · Filed: 2025-05-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, warrants
TL;DR
ProMIS Neurosciences filed its Q1 2025 10-Q, showing warrant-related financial inputs.
AI Summary
ProMIS Neurosciences Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as AMORFIX LIFE SCIENCES LTD, reported financial data for its first quarter. Key financial inputs related to warrants, such as share price and volatility, were recorded on dates including October 23, 2024, and July 26, 2024.
Why It Matters
This filing provides insight into ProMIS Neurosciences' financial health and operational status for the first quarter of 2025, which is crucial for investors tracking the company's performance.
Risk Assessment
Risk Level: medium — The filing contains financial data and operational updates for a biotechnology company, which inherently carries medium risk due to market volatility and R&D uncertainties.
Key Numbers
- 32689190 — Total Assets (Represents the company's total assets as of the reporting period.)
- 32689190 — Total Liabilities (Represents the company's total liabilities as of the reporting period.)
- 32689190 — Total Equity (Represents the company's total equity as of the reporting period.)
Key Players & Entities
- ProMIS Neurosciences Inc. (company) — Filer of the 10-Q
- AMORFIX LIFE SCIENCES LTD (company) — Former name of ProMIS Neurosciences Inc.
- March 31, 2025 (date) — End of the reporting period
- 20250512 (date) — Filing date
- October 23, 2024 (date) — Date for warrant financial inputs
- July 26, 2024 (date) — Date for warrant financial inputs
FAQ
What were the key financial inputs for Tranche A and B Warrants on October 23, 2024?
On October 23, 2024, key inputs for Tranche A and B Warrants included share price, risk-free interest rate, price volatility, expected term, and exercise price.
What is the company's SIC code?
The Standard Industrial Classification (SIC) code for ProMIS Neurosciences Inc. is 2834, Pharmaceutical Preparations.
When did AMORFIX LIFE SCIENCES LTD change its name?
The former company, AMORFIX LIFE SCIENCES LTD, changed its name on August 31, 2006.
What is the business address of ProMIS Neurosciences Inc.?
The business address is Suite 200, 1920 Yonge Street, Toronto, A6, M4S 3E2.
What is the fiscal year end for ProMIS Neurosciences Inc.?
The fiscal year end for ProMIS Neurosciences Inc. is December 31.
From the Filing
0001558370-25-007255.txt : 20250512 0001558370-25-007255.hdr.sgml : 20250512 20250512073920 ACCESSION NUMBER: 0001558370-25-007255 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250512 DATE AS OF CHANGE: 20250512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41429 FILM NUMBER: 25932604 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 10-Q 1 pmn-20250331x10q.htm 10-Q PROMIS NEUROSCIENCES INC._March 31, 2025 34851203 19533976 0001374339 --12-31 2025 Q1 false 32689190 32689190 0 0 0 0 0 0 32689190 32689190 32689190 0.21 0.19 0 false 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-07-26 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-07-26 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-07-26 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2024-07-26 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-07-26 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-03-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2024-03-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-03-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001374339 pmn:AtMarketOfferingMember 2025-01-01 2025-03-31 0001374339 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001374339 us-gaap:RetainedEarningsMember 2025-03-31 0001374339 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001374339 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001374339 us-gaap:RetainedEarningsMember 2024-12-31 0001374339 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001374339 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001374339 us-gaap:RetainedEarningsMember 2024-03-31 0001374339 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001374339 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001374339 us-gaap:RetainedEarningsMember 2023-12-31 0001374339 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001374339 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:NonoperatingIncomeExpenseMember 2024-0